![Mohammed Dar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mohammed Dar
Technik-/Wissenschafts-/F&E-Leiter bei IMMUNOCORE HOLDINGS PLC
Profil
Mohammed M.
Dar is currently the Chief Medical Officer & SVP-Clinical Development at Immunocore Holdings Plc.
Prior to this, he worked as the Vice President-Oncology Clinical Development at MedImmune LLC from 2013 to 2019.
Dr. Dar holds a doctorate degree from Duke University School of Medicine and an undergraduate degree from North Carolina State University.
Aktive Positionen von Mohammed Dar
Unternehmen | Position | Beginn |
---|---|---|
IMMUNOCORE HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2019 |
Ehemalige bekannte Positionen von Mohammed Dar
Unternehmen | Position | Ende |
---|---|---|
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.04.2019 |
Ausbildung von Mohammed Dar
North Carolina State University | Undergraduate Degree |
Duke University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IMMUNOCORE HOLDINGS PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |